Henry Schein (NASDAQ:HSIC) rose 7.4% amid a report that an activist investor has taken a stake and is pushing for the ...
Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut ...
Dental supply company Henry Schein reported total net sales of $3.2 billion during the third quarter of 2024, according to a Nov. 5 financial report. Here are eight things to know: 1. Third-quarter ...
Henry Schein (NASDAQ:HSIC) advanced 5.3% following a 3.3% increase on Friday amid some speculation the dental products ...
The dental supplies firm raised the lower end of its 2024 adjusted earnings projection, and now anticipates a range between $4.74 and $4.82 a share, compared with the prior $4.70-to-$4.82 a share ...
Henry Schein posts Q3 adjusted EPS of $1.23, topping forecasts, while sales of $3.17 billion fall short. The company revises ...
Analyst Erin Wright of Morgan Stanley maintained a Sell rating on Henry Schein (HSIC – Research Report), retaining the price target of ...